Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Integration of Traditional Chinese Medicine Xu Gua Therapy With Mesenchymal Stem Cells for the Treatment of Crohn's Disease-Associated Anal Fistula.

NCT07113795 is registered in ClinicalTrials.gov with The Anorectal Center of Nanjing Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT07113795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07113795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Integration of Traditional Chinese Medicine Xu Gua Therapy With Mesenchymal Stem Cells for the Treatment of Crohn's Disease-Associated Anal Fistula.
Lead sponsor
The Anorectal Center of Nanjing Hospital of Traditional Chinese Medicine
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
July 1, 2022
Completion date
June 30, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease with perianal fistulas